Treculia africana
Treculia africana · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Treculia africana, commonly known as the African breadfruit, is a significant medicinal plant widely utilized in traditional healing practices. Recent pharmacological investigations have focused on its potential therapeutic properties, particularly in managing metabolic disorders such as Diabetes Mellitus. Scientific interest has increasingly turned toward the bioactive compounds found within its foliage to address glycemic control. Specifically, researchers have employed methanol leaf extract to isolate and study the concentrated phytochemical constituents of the plant. This study aims to evaluate the efficacy of such extracts in mitigating the physiological complications associated with diabetic conditions.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Moraceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Treculia africana is a versatile species recognized by a diverse array of regional monikers. In many English-speaking areas, it is widely known by its common names, African Breadfruit and African-boxwood. Its cultural significance is further reflected in Portuguese-speaking regions, where it is called Feijão-africano and Fruta-pão-africana. These various titles highlight the plant's widespread presence across different linguistic landscapes. Ultimately, regardless of which name is used, the species remains a vital botanical resource.
Sources: Catalogue of Life (COL)
Taxonomy
Treculia africana is a distinctive species belonging to the vast kingdom Plantae. Within this expansive biological group, it is classified under the class Equisetopsida. Its taxonomic journey continues through the order Rosales, which helps define its evolutionary placement. The plant is further categorized into the family Moraceae, showcasing its close ties to other fig species. Ultimately, it is identified by its specific genus, Treculia, which distinguishes it within the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Rosales |
| Family | Moraceae |
| Genus | Treculia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Treculia africana is a widely distributed species found across various regions of the African continent. Its presence is noted throughout East Tropical Africa, specifically within the countries of Tanzania and Uganda. The plant also extends into Northeast Tropical Africa, spanning the territories of Sudan and South Sudan. Moving toward the southern regions, it can be located within South Tropical Africa in both Angola and Malawi. This diverse range highlights the plant's ability to adapt to many different tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Treculia africana is a robust, self-supporting tree that establishes a significant presence in its natural habitat. This species is characterized by a sturdy growth form that allows it to reach impressive proportions. Depending on environmental conditions, it can achieve a height of up to 27.5 meters. In ideal circumstances, the tree may even reach a maximum height of approximately 36.58 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Treculia africana leaf extracts have demonstrated significant potential in managing hyperglycemia-related disorders through their bioactive components. Phytochemical analysis using HPLC-DAD confirmed that these extracts contain chlorogenic acid and α-mangostin. The presence of chlorogenic acid is particularly noteworthy given the plant's ability to inhibit α-glucosidase activity in a concentration-dependent manner. Because these extracts showed very low cytotoxicity in human colorectal cells, they appear to be a safe candidate for further pharmacological study. Ultimately, the identification of chlorogenic acid supports the traditional medicinal use of these leaves for controlling blood glucose levels.
Conditions
Treculia africana demonstrates significant medicinal potential by treating diabetes mellitus and various hyperglycaemia-related disorders through the inhibition of α-glucosidase activity. The leaf extracts of this plant also effectively treat albumin glycation by inhibiting ribose-induced processes in bovine serum albumin. Research indicates that Treculia africana treats anti-plasmodial activities, showing moderate inhibitory effects against malaria parasites. Furthermore, the plant treats antioxidant requirements by exhibiting a superoxide dismutase (SOD) effect of greater than 50%. Together, these properties highlight the multifaceted therapeutic value of the species in managing metabolic and parasitic conditions.
Preparations
Treculia africana is prepared as a methanol leaf extract to investigate its potential therapeutic properties against hyperglycaemia-related disorders. This specific methanol extract demonstrates a significant concentration-dependent inhibition of α-glucosidase activity. Through phytochemical analysis, researchers identified key compounds such as chlorogenic acid and α-mangostin within this methanol preparation. The extract also shows a capacity to inhibit ribose-induced glycation of bovine serum albumin. Ultimately, the efficacy of this methanol leaf extract supports the traditional medicinal use of the plant for controlling blood glucose levels.
Parts used
Treculia africana possesses leaves that serve as a significant source of bioactive compounds for medicinal research. Recent studies have focused on utilizing leaf extracts to investigate their potential antidiabetic properties and ability to inhibit α-glucosidase activity. Chemical analysis of these extracts revealed the presence of key phytochemicals, specifically chlorogenic acid and α-mangostin. Furthermore, the methanol leaf extract demonstrated a concentration-dependent ability to manage hyperglycemia without showing significant cytotoxicity in human cell lines. These findings suggest that the leaves of this species hold great promise for future clinical applications in the treatment of diabetes mellitus.